• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION EMBLEM MRI S-ICD; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (NON-CRT)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION EMBLEM MRI S-ICD; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (NON-CRT) Back to Search Results
Model Number A219
Device Problems High impedance (1291); Inappropriate/Inadequate Shock/Stimulation (1574); Inaccurate Synchronization (1609)
Patient Problems Cardiac Arrest (1762); Electric Shock (2554)
Event Date 04/05/2023
Event Type  Injury  
Manufacturer Narrative
At this time, the product has not been returned.If the product is returned, analysis will be performed and this report would be updated at that time.
 
Event Description
It was reported that the patient arrived at the hospital in cardiac arrest and was intubated.The patient has a subcutaneous implantable cardioverter defibrillator (s-icd) implanted along with another manufacturer's cardiac resynchronization therapy pacemaker (crt-p) and epicardial leads in the abdomen.The epicardial leads appear to be the switched in the header as the unipolar right ventricle lead is connected in the left ventricle connector, and the bipolar left ventricle lead is connected in the right ventricle connector.Upon interrogation, the patient was in bi-ventricular pacing mode and the memory of the s-icd showed 11 shocks in seven episodes.The first five shocks were noted to be inappropriate and the last one of them induced the patient into ventricular fibrillation (vf).This arrhythmia was efficiently treated after four shocks in two different episodes.Therapy was exhausted in one of the episodes.X-ray was taken and new screening was performed to assess if a different location for the s-icd system would yield appropriate sensing.The screening passed in supine position using pacing bipolar mode.However, under the spontaneous rhythm the screening did not pass in any sensing vector due to low r to t ratios.It was further noted that there was high shock and system impedance.A revision procedure was performed where the s-icd and electrode were explanted.During the procedure it was noted that the system appeared to be more superficial with a subcutaneous pocket and no optimal lead placement.The new s-icd system was implanted with a new intermuscular pocket and a new vertical tunnelling.It was also placed higher and deeper than the previous system and yielded a good induction test along with within range measurements.No additional adverse patient effects were reported.
 
Event Description
It was reported that the patient arrived at the hospital in cardiac arrest and was intubated.The patient has a subcutaneous implantable cardioverter defibrillator (s-icd) implanted along with another manufacturer's cardiac resynchronization therapy pacemaker (crt-p) and epicardial leads in the abdomen.The epicardial leads appear to be the switched in the header as the unipolar right ventricle lead is connected in the left ventricle connector, and the bipolar left ventricle lead is connected in the right ventricle connector.Upon interrogation, the patient was in bi-ventricular pacing mode and the memory of the s-icd showed 11 shocks in seven episodes.The first five shocks were noted to be inappropriate and the last one of them induced the patient into ventricular fibrillation (vf).This arrhythmia was efficiently treated after four shocks in two different episodes.Therapy was exhausted in one of the episodes.X-ray was taken and new screening was performed to assess if a different location for the s-icd system would yield appropriate sensing.The screening passed in supine position using pacing bipolar mode.However, under the spontaneous rhythm the screening did not pass in any sensing vector due to low r to t ratios.It was further noted that there was high shock and system impedance.A revision procedure was performed where the s-icd and electrode were explanted.During the procedure it was noted that the system appeared to be more superficial with a subcutaneous pocket and no optimal lead placement.The new s-icd system was implanted with a new intermuscular pocket and a new vertical tunnelling.It was also placed higher and deeper than the previous system and yielded a good induction test along with within range measurements.No additional adverse patient effects were reported.
 
Manufacturer Narrative
At this time, the product has not been returned.If the product is returned, analysis will be performed and this report would be updated at that time.This product has not been returned to boston scientific, and as a result, laboratory analysis could not be conducted.Investigation of the available information determined this device's delivery of a shock may have contributed to unintentional induction of or acceleration of an arrhythmia.Please refer to the description for more information regarding the specific circumstances of this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EMBLEM MRI S-ICD
Type of Device
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (NON-CRT)
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key16761050
MDR Text Key313494824
Report Number2124215-2023-18215
Device Sequence Number1
Product Code LWS
UDI-Device Identifier00802526584404
UDI-Public00802526584404
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
P110042/S058
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/12/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/18/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date12/07/2018
Device Model NumberA219
Device Catalogue NumberA219
Device Lot Number204614
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/03/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/15/2016
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Hospitalization; Required Intervention;
Patient Age67 YR
-
-